Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression
Affective and Cognitive Consequences of ECT
2 other identifiers
interventional
180
1 country
1
Brief Summary
This study will compare four types of electroconvulsive therapy to determine if they differ in their effects on mood, thinking, brain activity, and biochemistry in people with major depressive disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 depression
Started Dec 1998
Longer than P75 for phase_4 depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 1998
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2005
CompletedFirst Submitted
Initial submission to the registry
June 15, 2007
CompletedFirst Posted
Study publicly available on registry
June 18, 2007
CompletedAugust 18, 2014
June 1, 2007
4 years
June 15, 2007
August 15, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Short-term antidepressant efficacy
Primary outcome reflected change in HRSD depression symptom scores.
Measured immediately post-treatment and 2, 4, and 6 months post-treatment
Specific acute, short-term, and long-term objective and subjective cognitive outcome measures (e.g., autobiographical amnesia, global self-rating of amnesia)
Specific neuropsychological measures were preselected as primary in safety analyses
Measured immediately post-treatment and 2, 4, and 6 months post-treatment
Secondary Outcomes (3)
Antidepressant efficacy
Measured immediately post-treatment and 2, 4, and 6 months post-treatment
Assessments of functional outcomes
Measured immediately post-treatment and 2, 4, and 6 months post-treatment
Memory, non-memory, and executive functions (acute, short-term, and long-term measures)
Measured immediately post-treatment and 2, 4, and 6 months post-treatment
Study Arms (4)
Ultrabrief, Right Unilateral ECT
EXPERIMENTALRight unilateral ECT administered with an ultrabrief pulse width (0.3 ms), at a dose 6 times the initial seizure threshold
Ultrabrief, Bilateral ECT (2.5 X ST)
EXPERIMENTALBilateral (frontotemporal) ECT with an ultrabrief pulse width with dosage 2.5 times the initial seizure threshold
Brief Pulse, Right Unilateral ECT
ACTIVE COMPARATORRight unilateral ECT, with a standard brief pulse (1.5 ms), with dosage 6 times the initial seizure threshold
Brief Pulse, Bilateral ECT
ACTIVE COMPARATORBilateral (frontotemporal) ECT with a standard brief pulse (1.5 ms), with dosage 2.5 times the initial seizure threshold
Interventions
Electroconvulsive therapy involves applying a small electrical charge to the scalp while the patient is anesthetized and provoking a short-lasting generalized seizure
Eligibility Criteria
You may qualify if:
- Diagnosis of major depressive disorder
- Pretreatment score of at least 18 on the Hamilton Rating Scale for Depression
- Able to tolerate psychotropic washout and no psychotropic medication, other than lorazepam (up to 3 mg/d PRN), during the study
- Recommended to receive ECT
You may not qualify if:
- History of schizophrenia, schizoaffective disorder, other functional psychosis, or rapid cycling bipolar disorder
- Secondary diagnosis of a delirium, dementia, or amnestic disorder, or epilepsy
- Pregnant
- History of neurological illness other than conditions associated with psychotropic exposure (e.g., tardive dyskinesia)
- History of alcohol or substance abuse within the year prior to study entry
- History of ECT within the 6 months prior to study entry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York State Psychiatric Institute
New York, New York, 10032, United States
Related Publications (2)
Sackeim, H. A.: The convulsant and anticonvulsant properties of electroconvulsive therapy: towards a focal form of brain stimulation. Clinical Neuroscience Review, 2004, 4:39-57.
RESULTSackeim HA, Prudic J, Nobler MS, Fitzsimons L, Lisanby SH, Payne N, Berman RM, Brakemeier EL, Perera T, Devanand DP. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul. 2008 Apr;1(2):71-83. doi: 10.1016/j.brs.2008.03.001.
PMID: 19756236RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harold A. Sackeim, PhD
New York State Psychiatric Institute
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2007
First Posted
June 18, 2007
Study Start
December 1, 1998
Primary Completion
December 1, 2002
Study Completion
May 1, 2005
Last Updated
August 18, 2014
Record last verified: 2007-06